Cargando…

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease

Rhinosinusitis is a feature of aspirin-exacerbated respiratory disease (AERD), which in the initial phase is manifested as nasal congestion, mostly affecting females at the age of around 30 years on average. Subsequently, nasal inflammation progresses to chronic eosinophilic rhinosinusitis, asthma,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia Cruz, Maria L., Jimenez-Chobillon, M. Alejandro, Teran, Luis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398631/ https://www.ncbi.nlm.nih.gov/pubmed/22829846 http://dx.doi.org/10.1155/2012/273752

Ejemplares similares

Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012)

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
por: Spielman, Daniel B., et al.
Publicado: (2020)

Blood Basophils Relevance in Chronic Rhinosinusitis with Aspirin-Exacerbated Respiratory Disease
por: Brescia, Giuseppe, et al.
Publicado: (2023)

Update on the Management of Aspirin-Exacerbated Respiratory Disease
por: Buchheit, Kathleen M., et al.
Publicado: (2016)

288 IL1B but not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus Aspirin Tolerant Asthmatics
por: Pavon Romero, Fernando Gandhi, et al.
Publicado: (2012)

Transcriptome Analysis Identifies Doublesex and Mab-3 Related Transcription Factor (DMRT3) in Nasal Polyp Epithelial Cells of Patients Suffering from Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease (AERD)
por: Priyadharshini, V.S., et al.
Publicado: (2021)

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
por: Li, Kevin L., et al.
Publicado: (2019)

Aspirin-Exacerbated Respiratory Disease: Evaluation and Management
por: Lee, Rachel U., et al.
Publicado: (2011)

Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease
por: Shrestha Palikhe, Nami, et al.
Publicado: (2012)

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
por: Steinke, John W, et al.
Publicado: (2016)

Appropriate extent of surgery for aspirin-exacerbated respiratory disease
por: Muhonen, Ethan G., et al.
Publicado: (2020)

Aspirin-exacerbated respiratory disease: Update on medical management
por: White, Andrew A., et al.
Publicado: (2020)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2009)

The IL1B-511 Polymorphism (rs16944 AA Genotype) Is Increased in Aspirin-Exacerbated Respiratory Disease in Mexican Population
por: Falfán-Valencia, Ramcés, et al.
Publicado: (2012)

Aspirin‐exacerbated respiratory disease: A review
por: Dominas, Christine, et al.
Publicado: (2020)

Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
por: Howe, Rachel, et al.
Publicado: (2014)

Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
por: Mastalerz, Lucyna, et al.
Publicado: (2021)

Endogenous cannabinoids may regulate chronic inflammation in aspirin-exacerbated respiratory disease
por: Levy, Joshua M.
Publicado: (2020)

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Ryan, Lindsey, et al.
Publicado: (2020)

The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
por: Comhair, Suzy A. A., et al.
Publicado: (2018)

Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping
por: Kaboodkhani, Reza, et al.
Publicado: (2021)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021)

Aspirin-Exacerbated Asthma
por: Varghese, Mathew, et al.
Publicado: (2008)

Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases
por: Shin, Seung-Woo, et al.
Publicado: (2014)

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
por: Schneider, Sven, et al.
Publicado: (2023)

Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease
por: Mortazavi, Negar, et al.
Publicado: (2017)

The Role of Mast Cells in Aspirin-Exacerbated Respiratory Disease (AERD) Pathogenesis: Implications for Future Therapeutics
por: Kuruvilla, Merin E, et al.
Publicado: (2020)

Which Factors Associated With Activated Eosinophils Contribute to the Pathogenesis of Aspirin-Exacerbated Respiratory Disease?
por: Choi, Youngwoo, et al.
Publicado: (2018)

Galectin-10 Is Released in the Nasal Lavage Fluid of Patients with Aspirin-Sensitive Respiratory Disease
por: Negrete-Garcia, Ma. Cristina, et al.
Publicado: (2012)

COVID-19 in a series of patients with aspirin-exacerbated respiratory disease
por: White, Andrew A., et al.
Publicado: (2021)

A Comparison of Sphenoid Sinus Osteoneogenesis in Aspirin-Exacerbated Respiratory Disease
por: Malfitano, Madison J., et al.
Publicado: (2020)

The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
por: Locke, Tran, et al.
Publicado: (2020)

A Complicated Case of Aspirin-Exacerbated Respiratory Disease With Kounis Syndrome
por: Shaw, Krista M, et al.
Publicado: (2023)

MS4A2-rs573790 Is Associated With Aspirin-Exacerbated Respiratory Disease: Replicative Study Using a Candidate Gene Strategy
por: Pavón-Romero, Gandhi F., et al.
Publicado: (2018)

Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease
por: Kong, Su-Kang, et al.
Publicado: (2016)

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial
por: Hayashi, Hiroaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o83h3b3po5aph889di6vjt8tl2